+157.2%
MRNA vs NVS
-12.1%
+169.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | NVS | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -0.2% | +5.6% | +5.9% |
| 7D | -1.1% | -14.3% | +13.2% | +29.8% |
| 30D | +126.1% | -10.0% | +136.1% | +192.3% |
| 3M | +190.0% | -10.9% | +200.9% | +278.8% |
| 6M | +157.2% | -12.0% | +169.2% | +240.3% |
| All | +157.2% | -12.1% | +169.3% | +240.3% |
Cumulative growth
Daily Returns
Daily percentage return beside NVS.
Daily Out/Under-Performance
Portfolio return minus NVS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded NVS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling